Neuralink’s First Human Patient: Progress in Brain-Computer Interface

The line between science fiction and medical reality blurred significantly in January 2024 when Neuralink, the neurotechnology company founded by Elon Musk, successfully implanted its first brain-computer interface (BCI) into a human subject. Since then, the patient has demonstrated remarkable abilities, including controlling a computer cursor and playing video games using only his thoughts. Here is a detailed look at the progress, the challenges faced, and what this means for the future of neurotechnology.

Meet Noland Arbaugh: The First Pioneer

The first recipient of the Neuralink implant is Noland Arbaugh, a 29-year-old man from Arizona. Eight years prior to the surgery, Arbaugh suffered a severe spinal cord injury during a diving accident. This left him with quadriplegia, meaning he has no movement or sensation below his shoulders.

Before the procedure, Arbaugh relied on a mouth stick (a stylus held in the mouth) to interact with digital devices. This method was slow and physically taxing. He volunteered for Neuralink’s PRIME Study (Precise Robotically Implanted Brain-Computer Interface) hoping to regain digital autonomy.

The surgery involved a robotic system placing a coin-sized device, often referred to as “The Link,” into his skull. The robot inserted 64 flexible threads, thinner than a human hair, directly into the motor cortex of his brain. These threads contain 1,024 electrodes designed to detect neural activity related to movement intention.

Capabilities: Gaming and Cursor Control

The primary goal of the initial trial was to assess safety and functionality. Specifically, the team wanted to see if Arbaugh could control a computer cursor. The results were immediate and impressive.

In a livestream demonstration on X (formerly Twitter) in March 2024, Arbaugh showed the world what the device could do. He played online chess with high proficiency, moving pieces across the board without physical assistance. He described the experience of moving the cursor as becoming “intuitive,” likening it to using “The Force” from Star Wars.

His achievements went beyond simple grid movements. Arbaugh reported playing the strategy game Civilization VI for eight hours straight. Before the implant, this would have required a caregiver to assist him constantly. With the Neuralink implant, he could lie in bed and play independently until the device’s battery needed recharging. He has also successfully played Mario Kart, competing against a friend.

How It Works

The process relies on decoding neural spikes. When Arbaugh thinks about moving his hand, the neurons in his motor cortex fire. The electrodes on the threads catch these electrical signals and transmit them wirelessly to an external app. The app then translates those brain signals into digital actions, such as moving a cursor up or to the left.

Challenges: The Retracting Threads

Despite the initial success, the trial faced a significant technical hurdle in the weeks following the surgery. Neuralink engineers discovered that a number of the ultra-thin threads had retracted (pulled back) from Arbaugh’s brain tissue.

This retraction resulted in a loss of data. With fewer electrodes in contact with the neurons, the system received fewer signals, which reduced the accuracy and speed of the cursor control. The bits-per-second (BPS) rate, a standard measure of BCI speed, dropped noticeably.

The company considered removing the implant but ultimately decided against it because no direct risk to Arbaugh’s safety was detected. Instead, they focused on a software-based solution.

The Software Fix

Neuralink engineers adjusted the recording algorithm to compensate for the lost data. They modified the system to be more sensitive to neural population signals rather than relying on specific single-neuron spikes. They also improved the techniques used to translate these signals into cursor movements.

Following these software updates, Arbaugh’s control accuracy not only recovered but reportedly exceeded his initial performance levels. This suggests that the hardware is robust enough to function even if connection points are less than perfect.

The PRIME Study and Future Goals

Noland Arbaugh is the first participant in the PRIME Study, but he will not be the last. The FDA-approved trial is designed to run for six years. The study aims to evaluate three things:

1. The Implant: The safety and durability of the N1 implant.
2. The Robot: The precision of the R1 surgical robot.
3. The App: The software’s ability to translate brain signals into commands.

Neuralink is currently seeking a second participant. The criteria for the next patient are similar: they are looking for individuals with limited or no ability to use both hands due to cervical spinal cord injury or Amyotrophic Lateral Sclerosis (ALS).

The long-term vision for the technology extends beyond cursor control. Musk has stated that future iterations, potentially named “Blindsight,” will aim to restore vision in people who are blind. Another goal is to bridge the connection between the brain and the spinal cord, theoretically allowing paralyzed individuals to walk again by bypassing the injury site.

Comparison to Other BCIs

While Neuralink gathers significant media attention, it is not the only player in the field.

• Synchron: This company has successfully implanted its “Stentrode” device in multiple patients. Unlike Neuralink, Synchron’s device enters the brain via blood vessels, requiring no open brain surgery.
• Blackrock Neurotech: A veteran in the space, their “Utah Array” has been used in research for nearly two decades, allowing patients to control robotic arms and type via mind-control.

Neuralink differentiates itself with the high number of electrodes (1,024) and the fully wireless nature of the implant, which is cosmetically invisible once the incision heals.

Frequently Asked Questions

Is the Neuralink implant safe? The FDA granted Neuralink an Investigational Device Exemption (IDE) to conduct human trials, meaning the agency reviewed safety data and deemed it acceptable for testing. However, as with any brain surgery, there are risks of infection, bleeding, or seizure. The long-term effects of the threads in the brain are still being studied.

Can the patient feel the implant? Noland Arbaugh has stated that he cannot feel the device in his head. The implant sits flush with the skull, and the brain itself has no pain receptors.

How is the device charged? The implant is charged wirelessly from the outside. The user wears a custom cap that induces power to the battery within the device.

When will this be available to the public? It is currently in the early clinical trial phase. It will likely take years of testing, data collection, and regulatory review before it becomes a commercially available medical product.

Did the thread retraction hurt the patient? No. Arbaugh reported no pain or adverse health effects from the threads retracting. The issue was purely technical regarding data capture.